Abstract
The present disclosure is directed to a compound of formula (I) (E266) and its acceptable pharmaceutical salts, to pharmaceutical compositions comprising the compound and its use in the manufacture of medicaments for treating diseases.
| Original language | English |
|---|---|
| Patent number | US20210309672A1 |
| State | Published - 7 Oct 2021 |